These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22829921)

  • 1. Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140.
    Arias MA; Van Roey GA; Tregoning JS; Moutaftsi M; Coler RN; Windish HP; Reed SG; Carter D; Shattock RJ
    PLoS One; 2012; 7(7):e41144. PubMed ID: 22829921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN Routes.
    McKay PF; King DF; Mann JF; Barinaga G; Carter D; Shattock RJ
    PLoS One; 2016; 11(2):e0148984. PubMed ID: 26862758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of TLR agonists as potential mucosal adjuvants for HIV gp140 and tetanus toxoid in mice.
    Buffa V; Klein K; Fischetti L; Shattock RJ
    PLoS One; 2012; 7(12):e50529. PubMed ID: 23272062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.
    Singh S; Yang G; Byrareddy SN; Barry MA; Sastry KJ
    Vaccine; 2014 Dec; 32(51):6934-6940. PubMed ID: 25444819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigen.
    Arias MA; Loxley A; Eatmon C; Van Roey G; Fairhurst D; Mitchnick M; Dash P; Cole T; Wegmann F; Sattentau Q; Shattock R
    Vaccine; 2011 Feb; 29(6):1258-69. PubMed ID: 21145913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization.
    Sundling C; Schön K; Mörner A; Forsell MNE; Wyatt RT; Thorstensson R; Hedestam GBK; Lycke NY
    J Gen Virol; 2008 Dec; 89(Pt 12):2954-2964. PubMed ID: 19008380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymic stromal lymphopoietin (TSLP) acts as a potent mucosal adjuvant for HIV-1 gp140 vaccination in mice.
    Van Roey GA; Arias MA; Tregoning JS; Rowe G; Shattock RJ
    Eur J Immunol; 2012 Feb; 42(2):353-63. PubMed ID: 22057556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and cellular response profiles induced by the TLR4 agonist-based adjuvant Glucopyranosyl Lipid A.
    Lambert SL; Yang CF; Liu Z; Sweetwood R; Zhao J; Cheng L; Jin H; Woo J
    PLoS One; 2012; 7(12):e51618. PubMed ID: 23284726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of protective antigen of Bacillus anthracis as a model recombinant antigen to evaluate toll-like receptors 2, 3, 4, 7 and 9 agonists in mice using established functional antibody assays, antigen-specific antibody assays and cellular assays.
    Inglefield J; Catania J; Harris A; Hickey T; Ma Z; Minang J; Baranji K; Spangler T; Look J; Ruiz C; Lu H; Alleva D; Reece JJ; Lacy MJ
    Vaccine; 2022 Sep; 40(38):5544-5555. PubMed ID: 35773119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal Vaccination against HIV-1 with Adenoviral Vector-Based Nanocomplex Using Synthetic TLR-4 Agonist Peptide as Adjuvant.
    Li M; Jiang Y; Gong T; Zhang Z; Sun X
    Mol Pharm; 2016 Mar; 13(3):885-94. PubMed ID: 26824411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of GLA/SE as an effective adjuvant for the induction of robust humoral and cell-mediated immune responses to EBV-gp350 in mice and rabbits.
    Heeke DS; Lin R; Rao E; Woo JC; McCarthy MP; Marshall JD
    Vaccine; 2016 May; 34(23):2562-9. PubMed ID: 27085175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses.
    Seydoux E; Liang H; Dubois Cauwelaert N; Archer M; Rintala ND; Kramer R; Carter D; Fox CB; Orr MT
    J Immunol; 2018 Jul; 201(1):98-112. PubMed ID: 29769270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations.
    Pattani A; McKay PF; Garland MJ; Curran RM; Migalska K; Cassidy CM; Malcolm RK; Shattock RJ; McCarthy HO; Donnelly RF
    J Control Release; 2012 Sep; 162(3):529-37. PubMed ID: 22960496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-γ.
    Desbien AL; Reed SJ; Bailor HR; Dubois Cauwelaert N; Laurance JD; Orr MT; Fox CB; Carter D; Reed SG; Duthie MS
    Eur J Immunol; 2015 Feb; 45(2):407-17. PubMed ID: 25367751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravaginal immunisation using a novel antigen-releasing ring device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses.
    McKay PF; Mann JF; Pattani A; Kett V; Aldon Y; King D; Malcolm RK; Shattock RJ
    J Control Release; 2017 Mar; 249():74-83. PubMed ID: 28115243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants.
    Desbien AL; Dubois Cauwelaert N; Reed SJ; Bailor HR; Liang H; Carter D; Duthie MS; Fox CB; Reed SG; Orr MT
    J Immunol; 2016 Dec; 197(11):4351-4359. PubMed ID: 27794001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
    Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses.
    Sakaue G; Hiroi T; Nakagawa Y; Someya K; Iwatani K; Sawa Y; Takahashi H; Honda M; Kunisawa J; Kiyono H
    J Immunol; 2003 Jan; 170(1):495-502. PubMed ID: 12496436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymeric penetration enhancers promote humoral immune responses to mucosal vaccines.
    Klein K; Mann JF; Rogers P; Shattock RJ
    J Control Release; 2014 Jun; 183():43-50. PubMed ID: 24657807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.